Treatment Overview
Benign Prostatic Hyperplasia (BPH), or prostate enlargement, is a common condition affecting men over 50, causing urinary symptoms such as weak urine flow, urgency, frequent urination, and incomplete bladder emptying. While BPH itself is non-cancerous, its symptoms can overlap with those of prostate cancer, making early detection crucial.
In Korea, healthcare providers offer integrated BPH management along with advanced prostate cancer screening. This combination ensures accurate diagnosis, timely intervention, and personalized treatment planning for men concerned about prostate health.
Purpose & Benefits
The purpose of combining BPH care with prostate cancer screening is to distinguish between benign enlargement and malignant conditions, ensuring optimal care. Benefits of screening and management in Korea include:
- Early detection of prostate cancer, even before symptoms appear
- Accurate differentiation between BPH and prostate malignancy
- Comprehensive evaluation of urinary function and prostate health
- Access to advanced diagnostic tools such as PSA testing, MRI, and biopsy
- Personalized treatment planning for BPH, cancer prevention, or combined therapy
- Expert care for international patients, including translation and coordinated appointments
- Peace of mind and proactive prostate health management
This integrated approach reduces risks and improves long-term outcomes for men with prostate concerns.
Ideal Candidates
Prostate cancer screening alongside BPH evaluation is recommended for men who:
- Are over 50 years of age or have a family history of prostate cancer
- Experience urinary symptoms such as weak stream, urgency, or frequency
- Have elevated PSA levels or abnormal digital rectal examination (DRE) results
- Are concerned about prostate cancer prevention
- Require comprehensive evaluation for both BPH and malignancy
- International patients seeking high-quality prostate health services in Korea
Korean urologists provide detailed assessments to ensure early detection and effective management.
Possible Risks & Complications
Screening and evaluation are generally safe, but minor considerations may include:
- Slight discomfort during physical examination or transrectal ultrasound (TRUS)
- Temporary mild bleeding or irritation during biopsy (if required)
- Rare allergic reaction to contrast agents used in imaging
- Anxiety related to screening results
Korean hospitals minimize these risks with advanced techniques, patient education, and professional support.
Techniques & Technology Used
Korea employs advanced technology for comprehensive BPH evaluation and prostate cancer screening:
Digital Rectal Examination (DRE)
- A physical examination to detect prostate abnormalities such as nodules or asymmetry.
Prostate-Specific Antigen (PSA) Test
- Blood test measuring PSA levels; elevated levels may indicate BPH, prostatitis, or prostate cancer.
Transrectal Ultrasound (TRUS)
- High-resolution imaging to assess prostate size, structure, and suspicious lesions.
Multiparametric MRI (mpMRI)
- Provides detailed imaging to detect early prostate cancer and guide biopsy procedures.
Prostate Biopsy
- Conducted if imaging or PSA levels indicate suspicious areas. Korea uses minimally invasive, precise techniques to ensure safety and accuracy.
Urodynamic Studies
- Assess bladder and urinary function to evaluate the impact of BPH and guide treatment planning.
Treatment Process in Korea
The process of BPH evaluation and prostate cancer screening is structured and patient-centered:
- Initial Consultation
- Comprehensive medical history, symptom assessment, and physical examination (DRE)
- Diagnostic Testing
- PSA blood test, urinalysis, TRUS, MRI, and urodynamic studies as indicated
- Evaluation & Risk Assessment
- Results reviewed by experienced urologists to distinguish BPH from malignancy
- If suspicious lesions are found, biopsy is performed under safe, sterile conditions
- Personalized Treatment Planning
- Options may include BPH management (medication or minimally invasive surgery), cancer surveillance, or treatment (surgery, radiation, or focal therapy)
- Follow-Up & Monitoring
- Regular PSA checks, imaging, and urinary symptom assessment
- Lifestyle counseling and preventive care to maintain prostate health
International patients receive translation support, appointment coordination, and remote follow-up options for convenience.
Recovery & After-Care
Recovery and after-care depend on the procedures performed:
- Consultation and Diagnostic Tests: No recovery needed; patients can resume daily activities immediately
- Prostate Biopsy: Mild discomfort, slight bleeding in urine or stool, and temporary urinary urgency may occur; usually resolves in a few days
- Post-Treatment (if surgery or minimally invasive BPH procedures are performed): Catheter care, hydration, activity guidelines, and medication management
- Long-Term Monitoring: Regular PSA tests, urodynamic assessments, and lifestyle modifications to maintain urinary and prostate health
Korean hospitals provide detailed post-procedure instructions to ensure patient safety and optimal outcomes.
Results & Longevity
Comprehensive BPH evaluation and prostate cancer screening in Korea offer:
- Accurate differentiation between benign and malignant prostate conditions
- Early detection of prostate cancer for timely treatment
- Effective management of BPH symptoms with minimal complications
- Long-term monitoring and preventive care for prostate health
- Improved quality of life with sustained urinary and sexual wellness
Early detection and proper management significantly reduce the risk of advanced disease and complications.
Why Korea Is a Top Destination
Korea is a preferred destination for BPH evaluation and prostate cancer screening due to:
- Highly skilled urologists with expertise in BPH and prostate cancer management
- Advanced diagnostic technology, including multiparametric MRI and precision biopsy techniques
- Integration of BPH care with cancer prevention and monitoring
- Affordable costs compared to Western countries
- Comprehensive support for international patients, including translation services and coordinated care
- High standards of patient safety, hygiene, and hospital infrastructure
These factors make Korea a reliable choice for men seeking comprehensive prostate health care.
Cost Range
The cost for BPH evaluation and prostate cancer screening in Korea varies depending on tests and procedures:
- Consultation: USD 50 – 150
- PSA Test: USD 50 – 100
- TRUS: USD 150 – 300
- Multiparametric MRI: USD 300 – 600
- Prostate Biopsy: USD 500 – 1,200
- Urodynamic Studies: USD 200 – 400
International packages may include consultation, diagnostics, biopsy (if needed), and follow-up care.
Popular Clinics in Korea
Top hospitals and clinics for BPH and prostate cancer screening include:
- Seoul National University Hospital (SNUH)
- Samsung Medical Center, Seoul
- Asan Medical Center, Seoul
- Severance Hospital (Yonsei University)
- St. Mary’s Hospital, Seoul
- Gangnam Urology Specialist Clinics
These centers provide expert urologists, advanced diagnostic tools, and comprehensive support for international patients.
